Zum Hauptinhalt springen

Hepatitiden

04. Dezember 2024 | Hepatitiden

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe...

22. November 2024 | Hepatitiden

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023.

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. Maticic M, Cernosa J, Loboda C, Tamse J, Rigoni R, Duffell...

10. November 2024 | Hepatitiden

Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program.

Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program. Choi SA, Umashankar K, Maheswaran A, Martin MT, Lee J, Odishoo M, Lin JY, Touchette DR. BMC Health Serv Res. 2024 Oct 30;24(...

10. November 2024 | Hepatitiden

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study. Lopes SS, Heo M, Pericot-Valverde I, Norton BL, Taylor LE, Tsui JI, Mehta SH, Feinberg J, K...

10. November 2024 | Hepatitiden

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard?

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard? Milošević I, Filipović A, Beronja B, Mitrović N, Ružić M, Simić J, Knežević N, Pete M, Todorović N, Nikolić N. Microor...

10. November 2024 | Hepatitiden

Association between Chronic Hepatitis B/C and Incidence of Osteoporosis and Bone Fractures: Results from a Retrospective Cohort Study.

Association between Chronic Hepatitis B/C and Incidence of Osteoporosis and Bone Fractures: Results from a Retrospective Cohort Study. Loosen SH, Killer A, Bock HH, Luedde T, Roderburg C, Kostev K. J Clin Med. 2024 Oct 16;13(20):6152...

10. November 2024 | Hepatitiden

Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study.

Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study. Olafsson S, Love TJ, Fridriksdottir RH, Tyrfingsson T, Runarsdottir V,...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten